Renaissance Technologies LLC Has $14.15 Million Stock Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Renaissance Technologies LLC raised its stake in Cellebrite DI Ltd. (NASDAQ:CLBT) by 22.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,183,700 shares of the company’s stock after acquiring an additional 214,600 shares during the quarter. Renaissance Technologies LLC owned about 0.57% of Cellebrite DI worth $14,145,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Parallel Advisors LLC increased its stake in shares of Cellebrite DI by 75.0% during the fourth quarter. Parallel Advisors LLC now owns 3,500 shares of the company’s stock worth $30,000 after purchasing an additional 1,500 shares during the period. Quarry LP bought a new position in Cellebrite DI during the 4th quarter worth $36,000. nVerses Capital LLC acquired a new stake in shares of Cellebrite DI during the second quarter worth $103,000. Central Asset Investments & Management Holdings HK Ltd bought a new stake in shares of Cellebrite DI in the fourth quarter valued at about $113,000. Finally, TD Asset Management Inc acquired a new position in shares of Cellebrite DI in the second quarter valued at about $121,000. 45.88% of the stock is currently owned by institutional investors and hedge funds.

Cellebrite DI Stock Performance

Shares of CLBT opened at $17.40 on Monday. Cellebrite DI Ltd. has a 52-week low of $6.36 and a 52-week high of $17.82. The firm has a market cap of $3.58 billion, a price-to-earnings ratio of -30.00, a PEG ratio of 2.41 and a beta of 1.52. The business’s fifty day moving average is $15.15 and its 200-day moving average is $12.68.

Cellebrite DI (NASDAQ:CLBT) last released its earnings results on Thursday, August 15th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. The firm had revenue of $95.70 million for the quarter, compared to analysts’ expectations of $91.94 million. Cellebrite DI had a positive return on equity of 5,902.06% and a negative net margin of 28.51%. The business’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.05 earnings per share. As a group, research analysts forecast that Cellebrite DI Ltd. will post 0.31 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have weighed in on CLBT shares. Craig Hallum lifted their price objective on shares of Cellebrite DI from $16.00 to $20.00 and gave the stock a “buy” rating in a research note on Friday, August 16th. Needham & Company LLC boosted their price target on Cellebrite DI from $14.00 to $17.00 and gave the company a “buy” rating in a research note on Friday, August 16th. JPMorgan Chase & Co. raised their price objective on Cellebrite DI from $14.00 to $15.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Bank of America lifted their price objective on Cellebrite DI from $13.00 to $17.00 and gave the company a “buy” rating in a report on Friday, August 16th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Cellebrite DI from $15.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. Seven research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $17.33.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.